May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Pharmocological Effects of Intravitreal Fluocinolone Acetonide in RCS Rats With Chronic Subretinal Prothesis Implants
Author Affiliations & Notes
  • K.R. Wong
    Ophthalmology, Kresge Eye Institute, Wayne State Univ., Ligon Research Center of Vision, Detroit, MI
  • I.V. Glybina
    Ophthalmology, Kresge Eye Institute, Wayne State Univ., Ligon Research Center of Vision, Detroit, MI
  • R. Buddi
    Ophthalmology, Kresge Eye Institute, Wayne State Univ., Ligon Research Center of Vision, Detroit, MI
  • S. Rabbani
    Wayne State University School of Medicine, Detroit, MI
  • J.P. McAllister
    Neurological Surgery & Ophthalmology, Wayne State School of Medicine, Detroit, MI
  • P. Ashton
    Control Delivery Systems Inc., Watertown, MD
  • G.W. Abrams
    Ophthalmology, Kresge Eye Institute, Wayne State Univ., Ligon Research Center of Vision, Detroit, MI
  • R. Iezzi
    Ophthalmology, Kresge Eye Institute, Wayne State Univ., Ligon Research Center of Vision, Detroit, MI
  • Footnotes
    Commercial Relationships  K.R. Wong, None; I.V. Glybina, None; R. Buddi, None; S. Rabbani, None; J.P. McAllister, None; P. Ashton, Controlled Delivery Systems E; G.W. Abrams, None; R. Iezzi, None.
  • Footnotes
    Support  Research to Prevent Blindness Career Development Award, Ligon Research Center of Vision, NIH LRP
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1510. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K.R. Wong, I.V. Glybina, R. Buddi, S. Rabbani, J.P. McAllister, P. Ashton, G.W. Abrams, R. Iezzi; Pharmocological Effects of Intravitreal Fluocinolone Acetonide in RCS Rats With Chronic Subretinal Prothesis Implants . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1510.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To examine the pharmacological effects of chronic intravitreal Fluocinolone Acetonide (FA) in RCS rats with subretinal polyimide implants (SI). Methods:Intravitreal drug delivery devices (IDDI) were inserted into RCS rats that received SI’s. Among 20 RCS rats aged 5.5 weeks, 5 received SI alone, 5 received SI and inactive IDDI and 10 received SI and FA–loaded IDDI. Active IDDI’s contained 75µg of FA, released at 3µg/day. Two weeks postoperatively, cell–count analysis of outer (ONL) and inner nuclear (INL) was performed using 40x H&E–stained photomicrographs for each of six regions, anterior, posterior, superior, inferior and overlying the temporally–placed subretinal impant and nasal to the disc. OCT and fundus photographs were obtained at weeks one and two. Results: OCT and fundus photographs showed no retinal detachments. Diffuse posterior subcapsular cataracts and corneal epitheliopathy developed in all animals that received an IDDI. This was more severe in the active IDDI group. Average ONL thickness among all regions for active IDDI+SI was 5.8 cells (sd: 0.97), inactive IDDI+SI 2.9 (sd:0.94) and SI only 2.9 (sd:1.2). Mean ONL thickness was statistically greater for the active IDDI+SI group as compared to inactive IDDI+SI (p=0.001) and SI only groups (p=0.01). Mean INL thickness among all regions for active IDDI+SI was 5.1 cells (sd: 0.47), inactive IDDI+SI 5.3 (sd:1.1) and SI only 5.0 (sd:0.39). No significant differences in INL thickness were measured for these three groups. Mean ONL thickness for unoperated fellow eyes was 2.2 (sd:0.55). This was not statistically different from the ONL thickness of the SI alone group. Conclusions: SI–implanted RCS rats that received intravitreal FA, demonstrated greater numbers of cells in the ONL as compared to animals that received inactive IDDI’s or SI’s alone. SI’s alone did not increase ONL or INL cell counts relative to unoperated fellow eye controls.

Keywords: retina • drug toxicity/drug effects • neuroprotection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×